EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review

Pier Mannuccio Mannucci iD, Craig M Kessler iD, Federico Germini, Francis Nissen, Richard Ofori-Asenso, Cristian Brocchieri, Sara Bendinelli, Alfonso Iorio iD

Haemophilia · 2023-07 · 29 (4) · 954-962

DOI: 10.1111/hae.14803 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Haemophilia, online erschienen am 08.06.2023. Verfasst von Pier Mannuccio Mannucci und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi, Hemophilia and Thrombosis Center, Milan, Italy. Hauptthemen laut MEDLINE: Hemophilia A, Hemostatics. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: F. Hoffmann-La Roche Ltd, Genentech, Inc., Genentech.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evidence on bleeding rates in people with congenital haemophilia A (PwcHA) without inhibitors on factor VIII (FVIII) replacement products is inconsistent.

Aim

This systematic literature review assessed bleeding outcomes in PwcHA using FVIII‐containing products as prophylactic treatment.

Methods

A search was conducted using the bibliographic databases Medline, Embase and Cochrane Central Register of Controlled Trials on the Ovid platform. The search involved a bibliographic review of clinical trial studies, routine clinical care studies and registries and a search of ClinicalTrials.gov, EU Clinical Trials Register and conference abstracts.

Results

The search yielded 5548 citations. A total of 58 publications were included for analysis. In 48 interventional studies, the pooled estimated mean (95% confidence interval [CI]) annualized bleeding rate (ABR), annualized joint bleeding rate (AJBR) and proportion of participants with zero bleeding events were 3.4 (3.0–3.7), 2.0 (1.6–2.5), and 38.5% (33.1–43.9), respectively. In 10 observational studies, the pooled estimated mean (95% CI) ABR, AJBR and proportion of participants with zero bleeding events were 4.8 (4.0–5.5), 2.6 (2.1–3.2), and 21.8% (19.9–47.5), respectively. A large variation in mean effect size for ABR, AJBR and zero bleeding event data across cohorts and cohort types was observed. Funnel plots indicated potential reporting bias for publications incorporating ABR and AJBR data across both interventional and observational studies.

Conclusion

This meta‐analysis shows that PwcHA without inhibitors still have bleeds despite FVIII prophylaxis. Improved standardization on capturing and reporting bleeding outcomes is needed so that effective comparisons between treatments can be made.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AHemostaticsHumansFactor VIIIHemorrhageHemarthrosis

Stichwörter der Autor:innen

factor VIIIhaemophilia Aliteraturemeta-analysissystematic review

Substanzen

Factor VIIIHemostatics

Autor:innen und Institutionen

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi, Hemophilia and Thrombosis Center, Milan, Italy.
  • Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington District of Columbia, USA.
  • McMaster University, Hamilton, ON, Canada.
  • F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Real World Data Enabling Platform, Roche Products Ltd, Welwyn Garden City, UK.
  • Medical Affairs, F. Hoffmann-La Roche Ltd, Monza, Italy.

ORCID-Profile: Pier Mannuccio Mannucci, Craig M Kessler, Alfonso Iorio

Förderung

  • F. Hoffmann-La Roche Ltd
  • Genentech, Inc.
  • Genentech

Zitieren

APA

Mannucci, P. M., Kessler, C. M., Germini, F., Nissen, F., Ofori-Asenso, R., Brocchieri, C., Bendinelli, S., & Iorio, A. (2023). Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review. Haemophilia, 29(4), 954-962. https://doi.org/10.1111/hae.14803

Vancouver

Mannucci PM, Kessler CM, Germini F, Nissen F, Ofori-Asenso R, Brocchieri C, et al. Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review. Haemophilia. 2023;29(4):954-962. doi:10.1111/hae.14803

BibTeX
@article{Mannucci2023,
  author = {Mannucci, Pier Mannuccio and Kessler, Craig M and Germini, Federico and Nissen, Francis and Ofori-Asenso, Richard and Brocchieri, Cristian and Bendinelli, Sara and Iorio, Alfonso},
  title = {Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review},
  journal = {Haemophilia},
  year = {2023},
  volume = {29},
  number = {4},
  pages = {954--962},
  doi = {10.1111/hae.14803}
}
Kostenlos starten →